First patient dosed using oral PROTAC in development for neurodegenerative diseases
A clinical-stage biotechnology company creating a new class of drugs today (Feb 20) announced that a first subject has been dosed in a phase 1 clinical trial.
Archives for February 20, 2024
Florence Healthcare and Slope join forces to address site technology ecosystem demand
Connectivity for research site processes and research has strengthened significantly following a partnership between Florence Healthcare and Slope.
Patients with treatment-resistant depression sought for trial of psychedelic drug
Some forms of depression cannot be cured by current treatments including antidepressants or going to psychological counselling or psychotherapy.